www.ejcancer.com
Open in
urlscan Pro
104.18.124.114
Public Scan
Submitted URL: http://ejcancer.com/
Effective URL: https://www.ejcancer.com/
Submission Tags: tranco_l324
Submission: On March 07 via api from DE — Scanned from DE
Effective URL: https://www.ejcancer.com/
Submission Tags: tranco_l324
Submission: On March 07 via api from DE — Scanned from DE
Form analysis 3 forms found in the DOM
POST /action/doLogin?redirectUri=https%3A%2F%2Fwww.ejcancer.com%2F
<form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.ejcancer.com%2F" method="post"><input type="hidden" name="redirectUri" value="https://www.ejcancer.com/"><input type="hidden" name="referer" value="/"><input type="hidden"
name="ecommRedirect"><input type="hidden" name="code" value="ejc-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true">
<div class="input-group">
<div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login">
</div>
<div class="input-group">
<div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a>
<div class="actions"><a href="https://www.ejcancer.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div>
</div>
<div class="remember"><input type="checkbox" name="savePassword" id="6ee85045-2441-4b5c-8a4b-4c078d548375-remember" value="1" checked="checked"><label for="6ee85045-2441-4b5c-8a4b-4c078d548375-remember">Remember me</label></div>
<div class="submit" disabled="disabled"><input type="submit" name="submit" value="Log in" class="button submit primary" disabled="disabled"></div>
</form>POST /action/requestResetPassword
<form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="ejc-site">
<div class="input-group">
<div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email">
</div>
<div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div>
</form>Name: quickSearchBar — GET https://www.ejcancer.com/action/doSearch?journalCode=ejc
<form action="https://www.ejcancer.com/action/doSearch?journalCode=ejc" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type">
<div class="quick-search__toggle"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3"
data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search"
aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go
search</span></button><a href="https://www.ejcancer.com/search/advanced?SeriesKey=ejc&ISSN=0959-8049&journalCode=ejc" title="Advanced search" class="quick-search__advanced-link">Advanced search</a>
<ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul>
</div>
<div class="quick-search__box">
<div class="quick-search__box-inner">
<div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area">
<option value="AllField">All content</option>
<option value="Title">Article title</option>
<option value="Contrib">Authors</option>
<option value="Keyword">Keywords</option>
<option value="Abstract">Abstract</option>
<option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option>
</select><a href="https://www.ejcancer.com/search/advanced?SeriesKey=ejc&ISSN=0959-8049&journalCode=ejc" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div>
<a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a>
</div>
</div>
<div class="quick-search__alert hidden">
<p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a>
</div>
</form>Text Content
Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT
Open GPT Console
Open Oracle Keywords
Refresh Values
Property Value Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
* Submit
* Log in
* Register
* Log in
* Submit
* Log in
* Subscribe
* Claim
LOGIN TO YOUR ACCOUNT
Email/Username
Password
Show
Forgot password?
Remember me
Don’t have an account?
Create a Free Account
If you don't remember your password, you can reset it by entering your email
address and clicking the Reset Password button. You will then receive an email
that contains a secure link for resetting your password
Email*
If the address matches a valid account an email will be sent to __email__ with
instructions for resetting your password
Cancel
MASTHEAD
Supports Open Access
Skip menu
* Articles
*
* LATEST
* Articles in Press
* Issues in Progress
* Current Issue
* Past Issues
* Special Issues
* POPULAR ARTICLES
* Original research
LONG-TERM PATIENT-REPORTED OUTCOMES FROM MONARCHE: ABEMACICLIB PLUS
ENDOCRINE THERAPY AS ADJUVANT THERAPY FOR HR+, HER2-, NODE-POSITIVE,
HIGH-RISK, EARLY BREAST CANCER
Tolaney et al.
* Current perspective
EQUAL CENSORING BUT STILL INFORMATIVE: WHEN THE REASONS FOR CENSORING
DIFFER BETWEEN TREATMENT ARMS
Olivier et al.
* Original research
A MULTICENTER, RANDOMIZED PHASE 2 STUDY TO ESTABLISH COMBINATIONS OF
CBP501, CISPLATIN AND NIVOLUMAB FOR ≥3RD-LINE TREATMENT OF PATIENTS
WITH ADVANCED PANCREATIC ADENOCARCINOMA
Enzler et al.
* LATEST ARTICLES
* Corrigendum
CORRIGENDUM TO “RISK FACTORS FOR EARLY-ONSET PANCREATIC DUCTAL
ADENOCARCINOMA: A SYSTEMATIC LITERATURE REVIEW” [EUR J CANCER 198
(2024) 113471]
Chandana et al.
* Original Research
THE RANKL INHIBITOR DENOSUMAB IN COMBINATION WITH DUAL CHECKPOINT
INHIBITION IS ASSOCIATED WITH INCREASED CXCL-13 SERUM CONCENTRATIONS
Schaper-Gerhardt et al.
* Original Research
ANTI-PD-(L)1 PLUS BRAF/MEK INHIBITORS (TRIPLET THERAPY) AFTER FAILURE
OF IMMUNE CHECKPOINT INHIBITION AND TARGETED THERAPY IN PATIENTS WITH
ADVANCED MELANOMA
Albrecht et al.
* Publish
* FOR AUTHORS
* Submit Article
External Link
* Guide for Authors
* Aims & Scope
* Open Access Information
External Link
* Researcher Academy
External Link
* EJC Author Form
* Multimedia
* * Podcasts
* About
* SOCIETY
* Society Information
* Editorial Board
* EORTC
External Link
* EUSOMA
External Link
* JOURNAL INFORMATION
* Aims & Scope
* Abstracting & Indexing
* PracticeUpdate
External Link
* ACCESS
* Subscribe
* Activate Online Access
* Contact
* CONTACT
* Contact Us
* Advertise with Us
External Link
* Go to Product Catalog
External Link
* FOLLOW US
* New Content Alerts
* Twitter
External Link
Go searchAdvanced search
All contentArticle titleAuthorsKeywordsAbstractArticle title, abstract,
keywordsAdvanced search
Please enter a term before submitting your search.
Ok
Current Issue
European Journal of Cancer
March 2024Volume 200
CURRENT ISSUE LINKS
* Articles in Press
* Past Issues
SUBMIT MOBILE
* Submit article Opens in new window
EXPLORE
* Subscribe
* Info for Advertisers Opens in new window
* Special Issues
* PracticeUpdate Opens in new window
PUBLISH
* Submit Article Opens in new window
* Aims and Scope
* For Authors
* Supports Open Access Opens in new window
CONNECT
* Alerts
* Twitter Opens in new window
* EORTC Opens in new window
* EUSOMA Opens in new window
ARTICLES IN PRESS
* Corrigendum
CORRIGENDUM TO “RISK FACTORS FOR EARLY-ONSET PANCREATIC DUCTAL
ADENOCARCINOMA: A SYSTEMATIC LITERATURE REVIEW” [EUR J CANCER 198 (2024)
113471]
Chandana et al.
Published online: March 2, 2024
* Original Research
Open Access
THE RANKL INHIBITOR DENOSUMAB IN COMBINATION WITH DUAL CHECKPOINT INHIBITION
IS ASSOCIATED WITH INCREASED CXCL-13 SERUM CONCENTRATIONS
Schaper-Gerhardt et al.
Published online: March 2, 2024
* Original Research
Open Access
ANTI-PD-(L)1 PLUS BRAF/MEK INHIBITORS (TRIPLET THERAPY) AFTER FAILURE OF
IMMUNE CHECKPOINT INHIBITION AND TARGETED THERAPY IN PATIENTS WITH ADVANCED
MELANOMA
Albrecht et al.
Published online: March 1, 2024
* Original Research
DISEASE-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN HR+/HER2− EARLY
BREAST CANCER: A CORRELATION ANALYSIS
Untch et al.
Published online: March 1, 2024
View All
EJC PODCASTS
LISTEN NOW
Richard Marais (Cancer Research UK Manchester Institute, UK) finds that
circulating cell-free DNA is a surrogate marker of tumour burden in patients
with metastatic melanoma. He tells Helen Saul that a simple blood test could
predict overall survival.
Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden
and a prognostic biomarker for survival in metastatic melanoma patients
LISTEN NOW
Eric Lim (Royal Brompton and Harefield NHS Trust, London, UK) finds that lung
cancer among never-smokers is increasing dramatically. He tells Helen Saul that
if trends continue, never-smokers diagnosed with lung cancer could outnumber
smokers within the next 10 years.
Increasing frequency of non-smoking lung cancer: Presentation of patients with
early disease to a tertiary institution in the UK
LISTEN NOW
Yolande Lievens (Ghent University Hospital, Belgium) finds that radiotherapy is
underutilised even in Belgium, one of the best-resourced countries in Europe.
She discusses with Helen Saul a collaborative project involving the Belgium
Cancer Registry and the College for Physicians in Radiation Oncology.
Radiotherapy access in Belgium: How far are we from evidence-based utilisation?
LISTEN NOW
Simon Pernot (Hôpital Européen Georges-Pompidou, Paris France) says that
circulating tumour cells may be a valuable prognostic biomarker in advanced
gastric cancer. He tells Helen Saul that the new results could improve the
management of treatment.
Dynamic evaluation of circulating tumour cells in patients with advanced gastric
and oesogastric junction adenocarcinoma: Prognostic value and early assessment
of therapeutic effects
View all European Journal of Cancer Podcasts
ISSUE HIGHLIGHTS
* Original research
REAL-WORLD HEALTH-RELATED QUALITY OF LIFE OUTCOMES FOR PATIENTS WITH RESECTED
STAGE III/IV MELANOMA TREATED WITH ADJUVANT ANTI-PD1 THERAPY
Egeler et al.
Published online: February 3, 2024
* Research Article
Open Access
ASSOCIATION OF ANTIBIOTIC TREATMENT WITH SURVIVAL OUTCOMES IN TREATMENT-NAÏVE
MELANOMA PATIENTS RECEIVING IMMUNE CHECKPOINT BLOCKADE
Chorti et al.
Published online: January 18, 2024
* Letter
RESPONSE TO THE LETTER: HYPERPROGRESSION IN ADVANCED MELANOMA IS NOT
RESTRICTED TO IMMUNOTHERAPY
* Marie Fournier et al.
* Laurent Mortier
* Olivier Dereure
* Sophie Dalac
* Bastien Oriano
* Stéphane Dalle
* Céleste Lebbé
Published online: January 24, 2024
* Corrigendum
CORRIGENDUM TO “RE: PATHOLOGIC COMPLETE RESPONSES, LONG-TERM OUTCOMES, AND
RECURRENCE PATTERNS IN HER2-LOW VS. HER2-ZERO BREAST CANCER AFTER NEOADJUVANT
CHEMOTHERAPY: SEVERAL ISSUES ABOUT HER2 EXPRESSION AND NEOADJUVANT
CHEMOTHERAPY IN BREAST CANCER” [EUR J CANCER 180 (2023) 184–185]
Yang et al.
Published online: February 2, 2024
ABOUT
EUROPEAN JOURNAL OF CANCER
Official Journal of EORTC and EUSOMA
The European Journal of Cancer (EJC) integrates preclinical, digital,
translational, and clinical research in cancer, from epidemiology,
carcinogenesis and biology through to innovations in cancer treatment and
patient care. The journal publishes original research, reviews, previews,
editorial comments and correspondence.
The EJC is the official journal of the European Organisation for Research and
Treatment of Cancer (EORTC) and the European Society of Breast Cancer
Specialists (EUSOMA).
SOCIETY INFORMATION
METRICS
METRICS
8.4
2022 Impact Factor
8.4
2022 5-Year Impact Factor
0.03956
Eigenfactor Score
* More Journal Metrics Opens in new window
* Submit a Manuscript Opens in new window
* Time to Online Publication Opens in new window
MOST READ (LAST 30 DAYS)
* Original research
Open Access
LONG-TERM PATIENT-REPORTED OUTCOMES FROM MONARCHE: ABEMACICLIB PLUS ENDOCRINE
THERAPY AS ADJUVANT THERAPY FOR HR+, HER2-, NODE-POSITIVE, HIGH-RISK, EARLY
BREAST CANCER
Tolaney et al.
Published online: January 15, 2024
* Current perspective
Open Access
EQUAL CENSORING BUT STILL INFORMATIVE: WHEN THE REASONS FOR CENSORING DIFFER
BETWEEN TREATMENT ARMS
Olivier et al.
Published online: February 17, 2024
* Original research
Open Access
A MULTICENTER, RANDOMIZED PHASE 2 STUDY TO ESTABLISH COMBINATIONS OF CBP501,
CISPLATIN AND NIVOLUMAB FOR ≥3RD-LINE TREATMENT OF PATIENTS WITH ADVANCED
PANCREATIC ADENOCARCINOMA
Enzler et al.
Published online: February 21, 2024
* Editorial
NEW FIGO 2023 ENDOMETRIAL CANCER STAGING VALIDATION. WELCOME TO THE FIRST
MOLECULAR CLASSIFIERS AND NEW PATHOLOGICAL VARIABLES!
* Ignace Vergote et al.
* Xavier Matias-Guiu
Published online: September 27, 2023
* Original Research
Open Access
LONG-TERM SURVIVAL WITH IDH WILDTYPE GLIOBLASTOMA: FIRST RESULTS FROM THE
ETERNITY BRAIN TUMOR FUNDERS’ COLLABORATIVE CONSORTIUM (EORTC 1419)
Hertler et al.
Published online: May 8, 2023
* Review
Open Access
EORTC CONSENSUS RECOMMENDATIONS FOR THE TREATMENT OF MYCOSIS FUNGOIDES/SÉZARY
SYNDROME – UPDATE 2023
Latzka et al.
Published online: September 17, 2023
MOST CITED (PREVIOUS 3 YEARS)
* Home
* Access for Developing Countries
* Articles & Issues
* Articles in Press
* Current Issue
* Past Issues
* EJC Supplements
* Collections
* Special Issues
* Authors
* About Open Access
* Author Information
* EJC Author Form
* Researcher Academy
* Submit Manuscript
* Journal
* About Open Access
* About the Journal
* Abstracting/Indexing
* Activate Online Access
* Contact Information
* Editorial Board
* Info for Advertisers
* Pricing
* Sign up for e-Alerts
* Subscribe
* Societies
* EORTC
* EUSOMA
* Society Information
* PracticeUpdate
* More Periodicals
* Find a Periodical
* Go to Product Catalog
* Follow Us
* Twitter
* RSS Feed
--------------------------------------------------------------------------------
The content on this site is intended for healthcare professionals.
--------------------------------------------------------------------------------
We use cookies to help provide and enhance our service and tailor content. To
update your cookie settings, please visit the Cookie Settings for this site.
All content on this site: Copyright © 2024 Elsevier Inc., its licensors, and
contributors.
All rights are reserved, including those for text and data mining, AI training,
and similar technologies.
For all open access content, the Creative Commons licensing terms apply.
* Privacy Policy
* Terms and Conditions
* Accessibility
* Help & Contact
We use cookies that are necessary to make our site work. We may also use
additional cookies to analyze, improve, and personalize our content and your
digital experience. For more information, see ourCookie Policy
Cookie Settings Accept all cookies
COOKIE PREFERENCE CENTER
We use cookies which are necessary to make our site work. We may also use
additional cookies to analyse, improve and personalise our content and your
digital experience. For more information, see our Cookie Policy and the list of
Google Ad-Tech Vendors.
You may choose not to allow some types of cookies. However, blocking some types
may impact your experience of our site and the services we are able to offer.
See the different category headings below to find out more or change your
settings.
Allow all
MANAGE CONSENT PREFERENCES
STRICTLY NECESSARY COOKIES
Always active
These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.
Cookie Details List
FUNCTIONAL COOKIES
Functional Cookies
These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.
Cookie Details List
PERFORMANCE COOKIES
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site.
Cookie Details List
TARGETING COOKIES
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. If you do not allow these cookies, you will
experience less targeted advertising.
Cookie Details List
Back Button
COOKIE LIST
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Confirm my choices